Sign up
Quantellect · Congress · Trade Detail
PRXLPAREXEL International Corporation (PRXL) F ILINg S TATUS : New S UBHOLdINg O F : UBS Brokerage Account
RepublicanHouse

Carlos Curbelo bought PAREXEL International Corporation (PRXL) F ILINg S TATUS : New S UBHOLdINg O F : UBS Brokerage Account (PRXL)

Carlos Curbelo (R-FL), a U.S. Representative, has disclosed 2 trades in PAREXEL International Corporation (PRXL) F ILINg S TATUS : New S UBHOLdINg O F : UBS Brokerage Account (PRXL) since 2016, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Carlos Curbelo bought $1,001 - $15,000 of PAREXEL International Corporation (PRXL) F ILINg S TATUS : New S UBHOLdINg O F : UBS Brokerage Account (PRXL) on December 30, 2016. Since that trade, PRXL is up +0.00% against the S&P 500 up +277.98%, an outperformance of -277.98%.

Across these filings, Carlos Curbelo has been a balanced trader of PRXL (a buy-to-sell ratio of 1.00). The most recent disclosed PRXL transaction shown was dated April 5, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

PRXL trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2016–2017

Carlos Curbelo's PRXL trades vs the price

PRXL is up +0.00% since Carlos Curbelo bought on December 30, 2016, versus +277.98% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+277.98%
Outperformance vs S&P 500
-277.98%

All Carlos Curbelo PRXL trades

TradedTypeSizeReturnEst. profit
April 5, 2017SELL$1,001 - $15,000N/A
December 30, 2016BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Carlos Curbelo & PRXL trading FAQ

Is it legal for Carlos Curbelo to trade PAREXEL International Corporation (PRXL) F ILINg S TATUS : New S UBHOLdINg O F : UBS Brokerage Account (PRXL) stock?

Yes. Members of Congress are allowed to trade individual stocks, including PAREXEL International Corporation (PRXL) F ILINg S TATUS : New S UBHOLdINg O F : UBS Brokerage Account (PRXL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Carlos Curbelo buy PRXL?

Carlos Curbelo disclosed a purchase of $1,001 - $15,000 of PAREXEL International Corporation (PRXL) F ILINg S TATUS : New S UBHOLdINg O F : UBS Brokerage Account (PRXL) on December 30, 2016, according to public STOCK Act filings.

How has PRXL performed since Carlos Curbelo's trade?

Since Carlos Curbelo bought PRXL on December 30, 2016, the stock is up +0.00%, versus +277.98% for the S&P 500 over the same period, an outperformance of -277.98%.

How many times has Carlos Curbelo traded PRXL?

Carlos Curbelo has disclosed 2 PRXL trades since 2016 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional PRXL trades?

Quantellect tracks every disclosed congressional trade in PAREXEL International Corporation (PRXL) F ILINg S TATUS : New S UBHOLdINg O F : UBS Brokerage Account (PRXL) on the PAREXEL International Corporation (PRXL) F ILINg S TATUS : New S UBHOLdINg O F : UBS Brokerage Account congressional trading page, which aggregates filings across all members of Congress.

Carlos Curbelo's PRXL tradesAll congressional filings for PAREXEL International Corporation (PRXL) F ILINg S TATUS : New S UBHOLdINg O F : UBS Brokerage AccountCarlos Curbelo's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.